Menopausal clinical trials

Explore recruiting menopausal clinical trials.

Recruiting menopausal studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Menopausal trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Strategies for zoledronic acid post-denosumab discontinuation in postmenopausal osteoporosis

France

Therapeutic use (Phase IV) EU CTIS Study details

Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome (MOVIN-II study)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase III, Randomized, Double-Blind, Parallel Group, Multicenter Study to Compare Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of BP16 Versus EU-Prolia® in Women with Post- Menopausal Osteoporosis

Latvia, Estonia, Slovakia, Hungary, Poland, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women.

Czechia, Bulgaria

Human Pharmacology (Phase I)- Other EU CTIS Study details

The effect of transdermal 17-β-estradiol/progesterone supplementation on glucose regulation in peri- and postmenopausal women with type 1 and type 2 diabetes

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Bioequivalence of Progesterone Vaginal Insert 100 mg in Healthy Pre-Menopausal, Nonpregnant Female Subjects.

Portugal

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Menopausal trials by city

Menopausal in Toronto Menopausal in Vancouver Menopausal in Montreal Menopausal in Calgary Menopausal in Edmonton Menopausal in Ottawa Menopausal in Winnipeg Menopausal in Quebec City Menopausal in Hamilton Menopausal in Kitchener Menopausal in London Menopausal in Halifax Menopausal in New York Menopausal in Los Angeles Menopausal in Chicago Menopausal in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease